The interaction of amyloid b and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells

Cellular and Molecular Neurobiology

Volumn 32, Issue 1, 2012, Pages 141-147

  Du, Huan ^a   Li, Pengtao ^a   Wang, Jun ^c   Qing, Xuemei ^c   Li, Weihong ^b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Amyloid peptide; Brain endothelial cells; MMP 2 expression; Receptor for advanced glycation endproducts

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MMP2 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; IN VITRO STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR AMYLOIDOSIS; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CEREBROVASCULAR DISEASE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; VASCULARIZATION;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELLS, CULTURED; CEREBROVASCULAR DISORDERS; DISEASE PROGRESSION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC;

EID: 84856543572     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9744-8     Document Type: Article

References (38)

1. Atterns J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol 107:83-90 (Pubitemid 38159295)
2. Bailey TL, Rivara CB, Rocher AB, Hof PR (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26:573-578 (Pubitemid 38879242)
3. Basta G (2008) Receptor for advanced glycation end products and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 196:9-21
4. Chen X, Walker DG, Schmidt AM, Arancio O, Lue LF, Yan SD (2007) RAGE: A potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr Mol Med 7:735-742
5. De la Torre JC (2002) Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 33:1152-1162
6. Deane R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis ofAlzheimer's disease. Curr Alzheimer Res 4:191-197 (Pubitemid 46562394)
7. Du H, Li P, Pan Y, Li W, Hou J, Chen H, Wang J, Tang H (2010) Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model. Brain Res 1357:1-8
8. Engelhart MJ, Geerlings MI, Meijie J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: The Rotterdam study. Arch Neurol 61:668-672 (Pubitemid 38637682)
9. Frisch SM, Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9:701-706 (Pubitemid 27424927)
10. Girones X, Guuimera A, Cruz-Sanchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sanchez FF (2004) N epsilon carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. Free Radic Biol Med 36:1241-1247 (Pubitemid 38526318)
11. Golde TE, Eckman CB, Younkin SG (2000) Biochemical detection of Abeta isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochem Biophys Acta 1502:172-187 (Pubitemid 30433866)
12. Greenberg SM, Gurol ME, Rosand J, Smith EE (2004) Amyloid angiopathy related vascular cognitive impairment. Stroke 35:2616-2619 (Pubitemid 39458351)
13. Hardy J, Cullen K (2006) Amyloid at the blood vessel wall. Nat Med 12:756-757 (Pubitemid 44050057)
14. Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, Kalea AZ, Lu Y, Rosario RH, Oruganti S, Nikolla Z, Belov D, Lalla E, Ramasamy R, Yan SF, Schmidt AM (2008) Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/-mice. J Clin Invest 118:183-194
15. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM (1999) RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901 (Pubitemid 29375048)
16. Kawai M, Kalaria RN, Harik SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137:1435-1446
17. Koyama H, Yamamoto H, Nishizawa Y (2007) RAGE and soluble RAGE: Potential therapeutic targets for cardiovascular disease. Mol Med 13:625-635 (Pubitemid 350228723)
18. Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, Zhu L, Man SM, Chen YH (2009a) Amyloid binteraction with receptor for advanced glycation end production upregulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol 182:5778-5788
19. Li W, Li P, Hua Q, Hou J, Wang J, Du H, Tang H, Xu Y (2009b) The impact of paracrine signaling in brain microvascular endothelial cells on the survival of neurons. Brain Res 1287:28-38
20. Li W, Poteet E, Xie L, Liu R, Wen Y, Yang SH (2011) Regulation of matrix metalloproteinase 2 by oligomeric amyloid bprotein. Brain Res 1387:141-148
21. Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, Beal MF (2003) Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative disease. J Neurol Sci 207:71-76 (Pubitemid 36292132)
22. Lue LF, Yan SD, Stern DM, Walker DG (2005) Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 4:249-266 (Pubitemid 40754161)
23. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsycholpharmacol Biol Psychiatry 27:741-749 (Pubitemid 36966754)
24. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Immune system response in Alzheimer's disease. Can J Neurol Sci 16:516-527 (Pubitemid 19278363)
25. Mizoguchi H, Takuma K, Fukuzaki E, Ibi D, Someya E, Akazawa K, Alkam T, Tsunekawa H, Mouri A, Noda Y, Nabeshima T, Yamada K (2009) Matrix metalloprotease-9 inhibition improves amyloid b-mediated cognitive impairment and neurotoxicity in mice. J Pharmacol Exp Ther 331:14-22
26. Mlekusch R, Humpel C (2009) Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels. Neurosci Lett 466:135-138
27. Mun-Bryce S, Lukes A, Wallace J, Lukes-Marx M, Rosenberg GA (2002) Stromelysin-1 and gelatinaseAare upregulated before TNFa in LPS-stimulated neuroinflammation. Brain Res 933:42-49 (Pubitemid 34258533)
28. Ramasamy R, Vannucci SJ, Yan SD, Herold K, Yan SF, Schmidt AM (2005) Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiology 15:16R-28R (Pubitemid 41417992)
29. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949-955 (Pubitemid 32946067)
30. Tagliavini F, Ghiso J, Timmers WF, Giaccone G, Bugiani O, Frangione B (1990) Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest 62:761-767 (Pubitemid 20213695)
31. Tarkowski E (2002) Cytokines in dementia. Curr Drug Targets Inflamm Allergy 1:193-200
32. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9. Crit Rev Biochem Mol Biol 37:375-536 (Pubitemid 36071972)
33. Vinters HV (2001) Cerebral amyloid angiopathy: A microvascular link between parenchymal and vascular dementia? Ann Neurol 49:691-692
34. Wang H, Ward N, Boswell M, Katz DM (2006) Secretion of Brainderived neurotrophic factor from brain microvascular endothelial cells. Eur J Neurosci 23:1665-1670
35. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691 (Pubitemid 26282167)
36. Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Goldman GC, Stern D, SchmidtAM(1997)RAGE-Ab interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94:5296-5301 (Pubitemid 27214777)
37. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932 (Pubitemid 26171198)
38. Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511 (Pubitemid 33676585)